Diabetes News Articles
Google

Wednesday, August 27, 2008
Search Diabetes News  
Latest News » All Diabetes News » Diabetics To Touch 325 Million By 2025


Diabetics To Touch 325 Million By 2025
Obesity and inactive lifestyle plus a few other factors, will take the number of diabetic patients, all over the world, to an alarming 325Mn by the year 2025.


/Diabetes News Articles/ - NEW DELHI, June 22, 2006 - Sedentary lifestyle and obesity being the main reasons, more and more people are falling prey to the deadly disease know as "diabetes".

Out of the total 165Mn diabetic patients across the world, about 18Mn are in USA alone. Approximately 5% of these patients suffer from Type 1 diabetes, primarily caused by the destruction of insulin producing cells (the islet cells). However rest of them have Type 2 diabetes, characterized by abnormal insulin secretion and/or insulin resistance.

In its recently published market research report named, "New Developments in Insulin Delivery Systems (2006)", RNCOS has provided the following information about the looming prevalence of diabetes:

§ Number of diabetic patients is set to cross 200Mn by the year 2010 all over the world, while the same is expected to rise to a stunning 325Mn by 2025.
§ There'll be more than two fold growth in Africa, Middle East, South-East Asia, and Eastern Mediterranean by the year 2025. Regions such as Europe, North America, and South & Central America and Western Pacific aren't far behind.

As per experts at RNCOS, "An increase of 170% in the cases of diabetes is foreseen in developing countries and will jump to 42% in developed countries in the near future".

Salient Features of this Research
§ Analysis of current market trends.
§ Comprehensive discussion about the leading edge technologies.
§ Scope of main insulin delivery systems across the globe.
§ Profile discussion of the key players in this sector.
§ Discussion about various challenges & opportunities in front of the industry.
§ Classification of the main factors, influencing the latest developments in insulin delivery systems.

Profile discussion of key players including Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, and GlaxoSmithKline plc is covered in the report.

To purchase your copy: http://www.rncos.com/Report/IM040.htm
For more information about the report please visit www.rncos.com

Further Related Resources:


Press Release Contact Information:

Shushmul Maheshwari
RNCOS
CEO
29, 1st Floor, Patparganj Industrial area
Delhi, New Delhi
India 110092
Voice: 91-11-4214-1229
Fax: 91-11-4214-1229
Website: Visit Our Website

Royalty Free Images

Free Dating Site
Affordable & Effective Press Release Distribution